4//SEC Filing
Agger Mette Kirstine 4
Accession 0000950170-24-073126
CIK 0001604950other
Filed
Jun 12, 8:00 PM ET
Accepted
Jun 13, 5:00 PM ET
Size
5.2 KB
Accession
0000950170-24-073126
Insider Transaction Report
Form 4
Agger Mette Kirstine
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-06-11+19,750→ 19,750 totalExercise: $4.11Exp: 2034-06-11→ Common Stock (19,750 underlying)
Footnotes (1)
- [F1]This stock option vests in full upon the earlier of (i) June 11, 2025, or (ii) the next annual meeting of the Issuer's stockholders.
Documents
Issuer
scPharmaceuticals Inc.
CIK 0001604950
Entity typeother
Related Parties
1- filerCIK 0001722234
Filing Metadata
- Form type
- 4
- Filed
- Jun 12, 8:00 PM ET
- Accepted
- Jun 13, 5:00 PM ET
- Size
- 5.2 KB